 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || LCAR-BCDR Cells / Legend Biotech
Enrollment open: BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma (clinicaltrials.gov) - Sep 2, 2022
P1, N=32, Recruiting, Sponsor: Weijun Fu
Not yet recruiting --> Recruiting
- || LCAR-BCDR Cells / Legend Biotech
Trial initiation date: BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma (clinicaltrials.gov) - Aug 10, 2022
P1, N=32, Not yet recruiting, Sponsor: Weijun Fu
Not yet recruiting --> Recruiting Initiation date: May 2022 --> Aug 2022
- || LCAR-BCDR Cells / Legend Biotech
New P1 trial: BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma (clinicaltrials.gov) - May 16, 2022
P1, N=32, Not yet recruiting, Sponsor: Weijun Fu